In light of the COVID-19 pandemic, unanticipated supply chain disruptions and postponed FDA inspections have created significant risks and challenges for the global medical product manufacturing network. The recently enacted CARES Act and new FDA guidance have established a new framework for addressing supply chain disruptions through formal risk management plans. In this webinar, presenters will discuss regulatory requirements as well as strategies for developing a post-Coronavirus recovery action plan, how to implement and manage an effective plan, and how to be prepared for an establishment inspection, whether through record reviews or during on-site inspections post-crisis.
- +$150 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Virtual Learning FAQ
On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.
On-demand content can be played back on most devices.
If you have concerns, please click the Test Your System link to determine your device’s compatibility, as well as system requirements.
CLE credit is not currently available for pre-recorded sessions.